The Negative Blood Culture That Wasn't
A 58-year-old woman with a history of intravenous drug use is admitted with fever, chills, and a new systolic murmur. Two sets of blood cultures are drawn two hours apart from peripheral sites. The first set is collected into aerobic and anaerobic bottles; the second set is collected into two aerobic bottles only because the anaerobic bottle stock is depleted. Both sets are incubated in an automated continuous-monitoring system. At 18 hours the first aerobic bottle flags positive and Gram stain shows gram-positive cocci in clusters. The second set remains negative at 48 hours. The patient is started on empiric vancomycin. The laboratory supervisor asks whether the negative second set changes the interpretation.
1. How should the laboratory interpret the discordant blood culture sets, and what does the number of positive bottles tell you?
Read the worked answer
The discordant result does not mean the second set is truly negative; it means the second set has lower sensitivity. Blood culture yield depends on volume of blood per bottle and the number of bottles and sets. The second set used only aerobic bottles, so it lacked the anaerobic recovery and had less total volume. A single positive aerobic bottle with gram-positive cocci in clusters in a patient with fever and a new murmur is clinically significant and should be treated as a probable bloodstream infection. The laboratory should report the positive Gram stain immediately as a critical result, follow with identification and susceptibility, and note that the second set was collected with reduced volume and no anaerobic bottle. The absence of growth in a lower-volume set does not rule out bacteremia.
2. What process improvement would you recommend, and how would you communicate it without blaming the phlebotomist?
Read the worked answer
The root cause is a supply and workflow gap: anaerobic bottles were out of stock, so collectors improvised. The laboratory should implement a par-level check and a backup supply process, train collectors to draw the full set or to document deviations, and monitor blood volume per bottle as a quality indicator. Communication should focus on the system, not the individual: present the discordant case as an example of how bottle availability affects yield, and ask collectors for input on restocking. The laboratory should also verify that the automated system's negative-to-date reporting is clear and that critical Gram stain results are phoned within the policy window. Follow-up should include auditing sets per culture and volume per bottle for the next month.